| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Sep 11, 2025 | Camp4 Therapeutics Corp | 10% Owner | Buy | 100.0 | +1,307,189 | 76.18% | ✗ | $2M |
| Mar 13, 2025 | Mar 17, 2025 | FRACTYL HEALTH, INC. | Director | Buy | 90.0 | +8,550 | 100.00% | ✗ | $10K |
| Oct 15, 2024 | Oct 22, 2024 | Camp4 Therapeutics Corp | 10% Owner | Buy | 100.0 | +909,090 | 100.00% | ✗ | $10M |
| Oct 15, 2024 | Oct 15, 2024 | Camp4 Therapeutics Corp | 10% Owner | Buy | 100.0 | +909,090 | 100.00% | ✗ | $10M |
| Jun 25, 2024 | Jun 27, 2024 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -8,500 | -50.19% | ✓ | $2M |
| May 29, 2024 | May 31, 2024 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -21,700 | -72.01% | ✓ | $3.2M |
| Apr 8, 2019 | Apr 10, 2019 | Cyclerion Therapeutics, Inc. | Director | Buy | 100.0 | +626,117 | 8339.33% | ✗ | $10M |